Shorten Trial Timelines With Better Evidence Generation
By Colin Weller, VP, Product Management
The pharmaceutical industry faces challenges in bringing new drugs to patients, primarily due to the lengthy clinical trial process. One of the key factors contributing to the acceleration of clinical trials is the adoption of digital health technologies. These technologies have brought about significant improvements in trial timelines.
However, to fully unlock the potential of digital technologies and automation innovations, a holistic platform approach is necessary. Medable's single-system solution aims to drive this evolution by integrating various types of data and enabling more efficient and effective clinical trials. By streamlining processes and reducing timelines, the goal of achieving clinical trials within a single year, which may seem ambitious, is becoming more attainable.
Ultimately, the focus of these efforts is on improving the lives of patients through digital innovation in clinical trials. By shortening the time it takes for new drugs to reach the market, patients can gain access to potentially life-saving treatments much faster.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.